Berenberg Bank causes a sensation with positive revaluations of Redcare Pharmacy and DocMorris, now recommending both online pharmacies for purchase and significantly raising their price targets. This has generated great enthusiasm among investors and led to a veritable rally in the stock market: Redcare shares, formerly known as Shop Apotheke, increased by 5.19 percent to 134.70 euros in the MDAX, while DocMorris shares in Switzerland rose by an impressive 10.67 percent to 77.80 francs.

Trigger for this positive development was the mandatory launch of the electronic prescription (E-prescription) in Germany at the beginning of January. In view of this, analyst Gerhard Orgonas raised his target prices and now estimates the potential of both stocks significantly higher. For Redcare, he now sees a target of 190 euros, while previously it was at 120 euros. For DocMorris, the target was raised from 60 to 100 francs - an increase of a solid 40 percent.

The dynamics unleashed by the E-prescription in Germany play an important role here. Currently, over 400,000 E-prescriptions are being redeemed weekly, which corresponds to a growth of over 4000 percent compared to the 9000 prescriptions in June last year. The introduction of the E-prescription in online pharmacies is also becoming increasingly likely and could already take place in the first quarter of this year.

The expert from Berenberg therefore predicts an annual revenue growth of 100 percent for Redcare in German e-prescriptions from 2024. Market shares are also expected to be further increased, and rising margins as well as a positive free cash flow in the area of over-the-counter medications are expected to drive the stock price higher. With a current target price of 190 euros, the potential is therefore over 40 percent.

Orgonas expects annual growth of 100 percent in the E-prescription field for DocMorris' German business starting from 2024. For investors who have already invested in the stocks, this could mean a remaining potential gain of slightly over 20 percent. Both Redcare and DocMorris saw strong increases in stock prices last year - both stocks have approximately tripled.

Overall, Redcare is ranked number one among the most significant indices in the Dax family in terms of the highest price gains in 2023. However, the stock has slightly declined since its peak before Christmas. Nevertheless, the price has tripled in the past year, just like DocMorris. These positive developments make both online pharmacies promising investment opportunities for investors.